NEI 2025 Fall Congress: Key Themes and Insights
November 14, 2025
The 2025 NEI Fall Congress, held at The Broadmoor, brought together leading voices in psychiatry to discuss the field's rapid evolution. This year's meeting was defined not by the sheer number of sessions, but by the depth of conversation around psychiatry's future. Attendees explored how scientific advances, regulatory changes, and clinical experience are converging to reshape mental health care. The Congress provided a forum for candid dialogue on both emerging therapies and the enduring challenges clinicians face in practice.
Embracing Novel Therapies
- The FDA's approval of an adjunctive therapy for major depressive disorder set the tone for the meeting, highlighting regulatory openness to rapid-acting treatments.
- Presentations explored glutamatergic modulators, orexin-2 receptor antagonists, and metabolic agents such as GLP-1 analogues, signaling a broader range of options for difficult-to-treat depression.
- The message was clear: clinicians should prepare to integrate these emerging therapies with established approaches.
Schizophrenia: Focus on Stability and Function
- Discussions centered on maintaining remission in schizophrenia, with long-acting injectable antipsychotics identified as underutilized tools for relapse prevention.
- Tardive dyskinesia was addressed with an emphasis on early detection and the use of VMAT-2 inhibitors to prevent motor side effects.
- Sessions on negative and cognitive symptoms reinforced the importance of supporting patient function and well-being, beyond controlling psychosis.
The Human Element in Psychiatry
- A tribute to Vladimir Maletic sparked conversation about anhedonia, underscoring the need to restore pleasure as a treatment goal. Both behavioral and pharmacologic interventions were discussed.
- A session on artificial intelligence in psychiatry balanced optimism with caution, noting that technology is only as effective as the clinician using it.
Pediatric Psychiatry: Individualized Care
- Sessions on Tourette's, bipolar disorder, and sleep disorders stressed the importance of developmental context and tailoring interventions to both children and families.
- The focus was on early, holistic care rather than a checklist of medications.
HWP Perspective
The Congress made it clear that psychiatry is at a pivotal moment. Breakthrough agents and new modalities are on the horizon, but their true value will be realized only when they complement proven best practices. The ongoing discussions about movement disorders, anhedonia, and pediatric care reflect a growing commitment to improving quality of life and functional outcomes for patients. As the field advances, the challenge for clinicians and industry will be to thoughtfully integrate innovation into care that remains personal, practical, and patient-centered, ensuring that progress translates into meaningful change for those we serve.
